These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 22131356

  • 1. Prospective evaluation of an Australian pertussis toxin IgG and IgA enzyme immunoassay.
    May ML, Doi SA, King D, Evans J, Robson JM.
    Clin Vaccine Immunol; 2012 Feb; 19(2):190-7. PubMed ID: 22131356
    [Abstract] [Full Text] [Related]

  • 2. Development and validation of an Australian in-house anti-pertussis toxin IgG and IgA enzyme immunoassay.
    May ML, Evans J, Riley J, Lambkin G, Robson JM.
    Pathology; 2013 Feb; 45(2):172-80. PubMed ID: 23250035
    [Abstract] [Full Text] [Related]

  • 3. Assessment of IgA anti-PT and IgG anti-ACT reflex testing to improve Bordetella pertussis serodiagnosis in recently vaccinated subjects.
    Subissi L, Rodeghiero C, Martini H, Litzroth A, Huygen K, Leroux-Roels G, Piérard D, Desombere I.
    Clin Microbiol Infect; 2020 May; 26(5):645.e1-645.e8. PubMed ID: 31610300
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of a tetraplex microsphere assay for Bordetella pertussis antibodies.
    Prince HE, Lapé-Nixon M, Matud J.
    Clin Vaccine Immunol; 2006 Feb; 13(2):266-70. PubMed ID: 16467336
    [Abstract] [Full Text] [Related]

  • 8. Nasopharyngeal pertussis toxin IgA antibodies in the diagnosis of pertussis in Australian community patients.
    Norman D, Karimi M, Herbert A, Beaman MH.
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2259-2261. PubMed ID: 28707065
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative study.
    Xing D, Wirsing von König CH, Newland P, Riffelmann M, Meade BD, Corbel M, Gaines-Das R.
    Clin Vaccine Immunol; 2009 Mar; 16(3):303-11. PubMed ID: 19109448
    [Abstract] [Full Text] [Related]

  • 16. Clinical evaluation and validation of laboratory methods for the diagnosis of Bordetella pertussis infection: Culture, polymerase chain reaction (PCR) and anti-pertussis toxin IgG serology (IgG-PT).
    Lee AD, Cassiday PK, Pawloski LC, Tatti KM, Martin MD, Briere EC, Tondella ML, Martin SW, Clinical Validation Study Group.
    PLoS One; 2018 Mar; 13(4):e0195979. PubMed ID: 29652945
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of Western immunobloting to an enzyme-linked immunosorbent assay for the determination of anti-Bordetella pertussis antibodies.
    Merrigan SD, Welch RJ, Litwin CM.
    Clin Vaccine Immunol; 2011 Apr; 18(4):615-20. PubMed ID: 21307277
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.